Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02400710 · ClinicalTrials.gov registry record · NA
Clinician-Supported PTSD Coach vs. Self-Managed PTSD Coach
A NA study of PTSD, sponsored by Syracuse VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT02400710 is a NA study of PTSD that has completed, run by Syracuse VA Medical Center. The registered enrollment target is 20 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02400710, a NA study of PTSD, has completed, sponsored by Syracuse VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
PTSD Coach is a mobile application (app) that aims to teach individuals self-management strategies for symptoms of Post-traumatic Stress Disorder (PTSD). Despite PTSD Coach's use of evidence-based cognitive behavioral strategies there is still a need to test the effectiveness of the app in managing PTSD symptoms. There is research evidence that self-management programs are often underutilized, but that clinician contact can increase patient involvement. The addition of clinician support may enhance the utilization and effectiveness of the PTSD Coach. In Phase 1 the investigators propose to conduct stakeholder interviews with primary care (PC) and mental health (MH) leadership staff to investigate barriers and facilitators to implementing Clinician-Supported (CS-PTSD Coach) to increase the uptake, use, and impact of PTSD Coach by PC patients. The interviews will inform the development of a CS-PTSD Coach protocol and manual that will be used in phase 2. In phase 2 the investigators propose to conduct a feasibility study where 30 (20 eligible) PC Veterans with diagnostic-level or subthreshold PTSD symptoms will be randomized to receive Self-Managed (SM) PTSD Coach or CS-PTSD Coach. The investigators' specific aims are to 1) investigate the feasibility of recruiting and retaining participants and delivering the SM and CS conditions and 2) conduct a preliminary investigation of the efficacy of SM vs. CS. The investigators predict that CS will lead to greater treatment gains than SM. Effect sizes will be generated for the following outcomes: a) reductions in PTSD, depression, and general distress, and increases in health-related functioning, b) increases in knowledge about PTSD symptoms, PTSD management strategies, and patient coping self-efficacy, c) increases in initiation of tradition PTSD treatments.
Conditions Studied
Interventions
- BEHAVIORAL Clinician-Supported PTSD Coach
- BEHAVIORAL Self-Managed PTSD Coach
Study Locations (1)
New York
- Syracuse VMAC - Syracuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02400710
The ClinicalTrials.gov registry entry for NCT02400710 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (93% lower). The listed sponsor is Syracuse VA Medical Center, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which Clinician-Supported PTSD Coach is the first listed.
NCT02400710 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02400710 about?
NCT02400710 is a clinical study titled "Clinician-Supported PTSD Coach vs. Self-Managed PTSD Coach". PTSD Coach is a mobile application (app) that aims to teach individuals self-management strategies for symptoms of Post-traumatic Stress Disorder (PTSD). Despite PTSD Coach's use of evidence-based cognitive behavioral strategies there is still a need to test the effectiveness of the app in managing ...
What is the current status of trial NCT02400710?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-04. Estimated completion is 2014-12.
What conditions does trial NCT02400710 study?
This clinical trial studies the following conditions: PTSD.
What interventions are being tested in trial NCT02400710?
The interventions under investigation include: Clinician-Supported PTSD Coach (BEHAVIORAL), Self-Managed PTSD Coach (BEHAVIORAL).
Who is sponsoring clinical trial NCT02400710?
This trial is sponsored by Syracuse VA Medical Center, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02400710 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.